Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach—an Indian experience

Infliximab (IFX) therapy in inflammatory bowel disease (IBD) is associated with loss of response in half the patients, due to complex pharmacokinetic and immunological factors. Dashboard’s Bayesian algorithms use information from model and individual multivariate determinants of IFX concentration and can predict dose and dosing interval. To compare measured IFX concentrations in our laboratory with values predicted by iDose dashboard system and...